![]() |
Volumn 37, Issue 4, 2005, Pages 1792-1794
|
Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: Three-year results
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BASILIXIMAB;
COTRIMOXAZOLE;
CREATININE;
DACLIZUMAB;
GANCICLOVIR;
HLA DR ANTIGEN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
STEROID;
TACROLIMUS;
ACUTE GRAFT REJECTION;
BK VIRUS;
BLOOD PRESSURE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG USE;
FOLLOW UP;
GLOMERULUS FILTRATION RATE;
GRAFT FAILURE;
GRAFT SURVIVAL;
HEART DEATH;
HIGH RISK PATIENT;
HLA MATCHING;
HUMAN;
IMMUNOREACTIVITY;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY DISEASE;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
POLYOMA VIRUS;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
SIDE EFFECT;
SURGICAL PATIENT;
SURVIVAL RATE;
VEIN THROMBOSIS;
WEIGHT GAIN;
ANTIBODIES, MONOCLONAL;
CREATININE;
FOLLOW-UP STUDIES;
GLOMERULAR FILTRATION RATE;
GLUCOCORTICOIDS;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TESTING;
HUMANS;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
REOPERATION;
SURVIVAL ANALYSIS;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 20344374664
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.03.150 Document Type: Conference Paper |
Times cited : (6)
|
References (5)
|